The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
about
Know the enemy as well as the weapons in hand: the aberrant death pathways and therapeutic agents in chronic lymphocytic leukemiaCyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathwaysNucleophosmin overexpression is associated with poor survival in astrocytoma.Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cellsGermline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.Liposome-coated lipoplex-based carrier for antisense oligonucleotides.Apoptotic cell signaling in cancer progression and therapySET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.Neutrophil elastase and its therapeutic effect on leukemia cells.The STAT5b Pathway Defect and AutoimmunityBroad targeting of resistance to apoptosis in cancer.BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysisRoles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.What do we do with chronic lymphocytic leukemia with 17p deletion?The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia.Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabinePro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells.Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights.Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors.Negative regulation of immunoreceptor signaling by protein adapters: Shc proteins join the club.Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.ZGDHu-1 for cancer therapy.Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.
P2860
Q26781895-867E20B5-A457-4A39-B3DF-D3325DC21B43Q28584308-F5A17624-46BB-402B-A7F0-71A6990B6ABFQ30300125-A54CD7A6-AC8D-4EE8-803C-A364F538E18BQ34173253-3C7233C1-DB26-4E04-9AC8-42B0CBAC2EF3Q34193833-89AEB883-7FA7-416E-86F8-7885A5EBF1D2Q34292891-70FF54F7-049D-4EED-AC21-BAF1EA28E2B5Q35087432-63821111-0AEB-444F-A802-55C914448D8AQ35088734-58A6F28B-F385-4D8A-AA70-590D513B6F11Q35483640-9101B1D2-B941-4A83-9AF8-04E622B8F81EQ35919739-A54656D3-ABE3-4903-BB74-0081549C5CC6Q36162564-6A2A01B6-C21A-478B-AD44-B0D4DBE4670EQ36483749-60114DF7-43EB-4189-95F6-C323E5ADC3CCQ36984500-D609CDDB-E82D-4D87-81AC-BC5867C5F16EQ37865381-B48A3BF0-C7F8-4590-8CD9-90778CD2F372Q37978967-F41585B3-9606-4471-8E87-FBBF716ED78CQ38063170-6D395CD8-99C1-4736-81E2-46F52CB277B6Q38237264-119605CD-A575-4941-9609-5241757FCBA8Q38413580-D6477207-9DF3-4594-9EA5-B15561966234Q38457498-8709B346-BEFE-49E0-960B-90EA43E3FF19Q38754284-C15C73FB-3B07-4D9F-A3D7-25D5E18AF9BBQ38819260-FE3C99CD-66B2-4E9D-B985-4E205BE800ACQ39065374-1118F616-7B99-4EAC-8E26-4ABC24C75CD8Q39077324-73EE1DD9-F22F-4F78-8146-A64119034E04Q39572142-F088D7FA-5B64-4063-A509-8A56D060A77EQ42061450-4FF55FA9-043D-4450-92D0-6D177A9865AEQ42912126-C98E0EAE-7615-4D9B-9D3D-F2C75FEDCF78Q47695857-FD88CD1F-E6A2-494F-B169-5C903E1B7503Q49436424-8DFF5A95-A56E-4FD5-B245-AD2B1C88E485Q54584717-13B2DF34-CBEA-448A-8284-3C383081C019Q55280895-6DB71A82-8588-4956-B0CD-47DDDA358132
P2860
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@en
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@nl
type
label
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@en
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@nl
prefLabel
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@en
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@nl
P1433
P1476
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia.
@en
P2093
Andrea G S Buggins
Chris J Pepper
P304
P356
10.1016/J.LEUKRES.2010.03.011
P577
2010-03-31T00:00:00Z